Corporate Finance

Denver-based Xcimer Energy completes key experiments, advancing its methodical plan to turn the promise of laser fusion into a commercial reality.

New data from Ethisphere shows the world's most ethical companies beat the market by 8.2% and recover from downturns faster. What's their secret?

A new collaboration will use innovative protein binders to fight animal disease, bolstering global food security and public health under the One Health framework.

New preclinical data reveals a novel gene therapy that not only kills tumor cells but also boosts immunity, offering hope against drug-resistant lung cancer.

A new report reveals a massive 23% drop in car thefts, but hotspots in California and popular models like the Hyundai Elantra keep owners on alert.

Former PM Justin Trudeau's keynote at EuroFinance signals a new era where treasury leaders must master global politics to protect corporate finances.

ASM's flagship case competition reveals a pivotal shift in business strategy, emphasizing ESG integration, holistic thinking, and AI-driven future leadership.

As the EU AI Act's 2026 deadline looms, DEKRA becomes the first gatekeeper for high-risk biometric systems, a move shaping the future of AI trust.

Most insurers believe AI is their future, but a new report reveals only 14% have adopted it, leading to costly delays and a widening performance gap.

GDEV's CEO solidifies control by boosting his ownership to 37% while co-founder Boris Gertsovskiy completely divests. What does this mean for the gaming giant?

A new university-industry partnership aims to solve the key challenges of orbital computing, validating early bets on the future of decentralized AI.

Australia overhauls its immigration system with a 'precision' focus on high-skilled, high-earning workers. What does this mean for aspiring migrants?

Named to the Sifted 100, Gemba’s rapid rise highlights a market pivot from consumer apps to the foundational, 'invisible' plumbing of embedded finance.

SAB Biotherapeutics' public offering fuels late-stage trials for its promising T1D drug, SAB-142, aiming to change the treatment landscape.

Nestlé's U.S. arm is repurchasing $1.6 billion in debt. Explore the strategic move to optimize its balance sheet and what it means for investors.

The B2B startup is pioneering a 'Managed ABM Operating System,' betting that a hybrid of AI and expert services is the key to unlocking revenue.

With $7M from True Ventures, a Thiel Fellow's startup is building AI 'ops agents' to help America's small factories finally compete on a global scale.

DNA Script's global expansion brings benchtop DNA printers to new markets, promising to accelerate research and decentralize biotech supply chains.

A new partnership aims to bring Wall Street-style analysis to the booming collectibles market, turning passionate hobbies into data-driven asset classes.

Grocery AI leader Afresh expands its platform from the fresh aisle to the entire store, promising to end system fragmentation and boost profits and sustainability.